Trump Signals Unlikely Restrictions on Abortion Pills in Second Term

President-elect Donald Trump commits to maintaining FDA approval for abortion pills but leaves room for future policy changes.

Donald Trump, in a Time magazine interview, stated it is 'highly unlikely' his administration would restrict access to abortion pills mifepristone and misoprostol.
Trump's comments mark his clearest position yet on ensuring FDA approval for abortion pills remains intact during his presidency.
Anti-abortion groups, who have advocated for stricter regulations or bans, expressed disappointment but remain focused on reinstating in-person dispensing requirements.
The Biden administration had expanded access to abortion pills by lifting in-person requirements, allowing online sales and mail delivery of the medication.
While Trump committed to preserving FDA approval, he hinted at the possibility of revisiting related policies, such as invoking the Comstock Act, which could indirectly limit access.